4D PHARMA RESEARCH LTD
4D pharma Research Limited, a biotechnology company, develops drug compounds from gut bacteria for the prevention and treatment of inflammatory diseases.
4D PHARMA RESEARCH LTD
Industry:
Biotechnology
Founded:
2008-01-01
Address:
Aberdeen, Aberdeen City, United Kingdom
Country:
United Kingdom
Status:
Active
Contact:
+44 1224 900 460
Similar Organizations
Mucosis
Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.
Zytoprotec
Zytoprotec is an Austrian biotechnology company developing new treatment options for major disease areas.
More informations about "4D pharma Research Ltd"
4D Pharma Research Company Profile 2024: Valuation, Investors ...
Nov 26, 2012 4D Pharma Research General Information Description. Developer of Biotherapeutics for the treatment of autoimmune diseases. The company develops approved …See details»
4D pharma Announces Completion of Merger With Longevity …
Mar 22, 2021 About 4D pharma. 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological …See details»
4D PHARMA RESEARCH LIMITED - Companies House
Insolvency for 4D PHARMA RESEARCH LIMITED (SC336222) More for 4D PHARMA RESEARCH LIMITED (SC336222) Registered office address C/O Interpath Limited 5th Floor, …See details»
4D Pharma Research Ltd. - Life-Sciences-Europe.com
Mar 30, 2015 More documents for 4D Pharma (Group) [1] 4D Pharma plc. (10/8/19). "Press Release: 4D Pharma Collaborates with MSD to Develop Live Biotherapeutics for Vaccines"....See details»
4D Pharma Research Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore 4D Pharma Research Ltd. with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
4D Pharma’s Irish business in receivership – The Irish …
Feb 23, 2023 A deal to swap the Leeds, England-based 4D Pharma’s €13 million secured debt for shares in the business failed last week, leaving the group under the control of administrators appointed by ...See details»
4D PHARMA RESEARCH LIMITED - Companies House
4D PHARMA RESEARCH LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
4D Pharma - Funding, Financials, Valuation & Investors - Crunchbase
Their latest funding was raised on Jul 29, 2021 from a Post-IPO Debt round. 4D Pharma is registered under the ticker NASDAQ:LBPS . 4D Pharma is funded by Oxford Finance LLC. 4D …See details»
4D Pharma - Crunchbase Company Profile & Funding
4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a …See details»
A 4D lesson in early-stage investing - Investors' Chronicle
Mar 15, 2023 After Armistice had acquired all of 4D Pharma’s secured debt, the administrators began negotiating a debt-for-equity swap. Shareholders agreed to this on 16 January this …See details»
4D Pharma sinks into administration as creditor calls in loans
Jun 27, 2022 The company noted that its wholly owned subsidiaries—namely 4D Pharma Research Limited, 4D Pharma Cork Limited, 4D Pharma León S.L.U. and 4D Pharma …See details»
4D pharma Announces Positive Interim Results from the Phase I/II …
Mar 23, 2022 Conference Call & Webcast Information 4D pharma will host a conference call and live webcast on Wednesday, March 23, 2022, at 10:00 am ET (2:00 pm GMT) to discuss the …See details»
4D pharma Announces Completion of Merger With Longevity
Mar 19, 2021 About 4D pharma. 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological …See details»
4D pharma Announces FDA Clearance of IND Application for Live ...
Feb 22, 2022 4D pharma is collaborating with Parkinson's UK, a non-profit organization focused on advancing the understanding of Parkinson's disease and improving treatments, and has …See details»
4D Pharma expanding clinical data in multiple indications
Jun 28, 2021 Live biotherapeutic product (LBP) developer, 4D Pharma, says it is building a ‘strong body of evidence’ for its portfolio of bacterial strains in relation to cancer, asthma, and …See details»
4D Pharma: New data early indication LBPs may help to overcome ...
Mar 25, 2022 Duncan Peyton, CEO, 4D Pharma, told BioPharma-Reporter: “The primary endpoint for Part B set by 4D Pharma and MSD was for more than three patients out of a total …See details»
Merck signs deal with 4D Pharma for LBPs - biopharma-reporter.com
Oct 9, 2019 Merck extends its partnership with 4D Pharma to discover and develop LBP vaccines for three undisclosed indications, adding to their Keytruda partnership. Merck, known …See details»
4D pharma Reports Full Year 2021 Financial Results, Operational ...
Mar 31, 2022 4D pharma Investor Relations [email protected] Singer Capital Markets – Nominated Adviser and Joint Broker Philip Davies / James Fischer (Corporate Finance) +44 …See details»
4D Pharma confirms early potential of bacteria to ‘revolutionise ...
Jul 7, 2021 4D Pharma’s latest update focuses on a bacteria, Megasphaera massiliensis MRx1299, the company has identified using its drug discovery platform, which it calls MicroRX.See details»
Efficacy and safety of tezepelumab versus placebo in adults with ...
7 hours ago A significant reduction was not observed in the annualised rate of moderate or severe COPD exacerbations with tezepelumab versus placebo. Further studies are required to …See details»